A 68-year-old man with symptomatic, recurrent atrial fibrillation has failed rate control strategies and is planned for rhythm control with amiodarone. He has a history of coronary artery disease and heart failure with a left ventricular ejection fraction of 35%. You are planning his medication initiation and long-term follow-up. Arrange the following steps regarding the monitoring and treatment evaluation of this patient's amiodarone therapy in the correct chronological order, from baseline preparation to long-term surveillance.
- 1Obtain baseline serum aminotransferases, thyroid-stimulating hormone, chest radiograph, and pulmonary function tests.
- 2Monitor continuous telemetry for bradycardia and QT interval prolongation during the loading dose phase.
- 3Repeat thyroid-stimulating hormone and liver function tests at the 6-month follow-up visit.
- 4Conduct an annual clinical assessment with a chest radiograph and refer for a slit-lamp ophthalmic examination.
Answer
The correct chronological sequence is: 1) Baseline organ function testing, 2) Acute ECG monitoring during loading, 3) 6-month thyroid and liver function surveillance, and 4) Annual pulmonary and ophthalmic screening.
Amiodarone is a highly effective antiarrhythmic, but it carries a massive burden of potential systemic toxicities due to its lipophilicity, high iodine content, and extremely long half-life. Safe management requires a strict temporal protocol: establishing baseline pulmonary, hepatic, and thyroid function; securing the acute loading phase against proarrhythmias; conducting 6-month interval checks for thyroid and hepatic dysfunction; and maintaining annual checks for chronic pulmonary or ocular damage.
Step-by-Step Solution
Key Concept
Standardized monitoring protocol for amiodarone toxicity